ART reports that its bioresorbable stent promotes vessel lumen enlargement

PARIS, Nov. 2, 2011—Arterial Remodeling Technologies (“ART”) reported today that in vivo data strongly suggest that its second-generation bioresorbable stent promotes positive arterial remodeling in a post-angioplasty porcine model at three months follow- up. In addition, acute safety data are excellent: there have been more than 250 MACE- free consecutive implantations of its bioresorbable stent in its preclinical phase of development.


ART-News 111102